INFLIXIMAB TRADE DATA ANALYSIS
Analyze Infliximab export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
INFLIXIMAB – Overview
Eximpedia analyses Infliximab export import records, including data from 29 buyers and 25 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Infliximab Buyers, Suppliers & Shipments
Products Infliximab import markets
Gain insights into Product Infliximab with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30021590300 | 65.39 | 14 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30021511 | 8.03 | 7 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30021500 | 6.95 | 20 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3002150000 | 2.70 | 2 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30029000 | 0.63 | 1 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| IRELAND | 48.01 | 3 | 0.00 |
| SWITZERLAND | 13.61 | 23 | 0.00 |
| GERMANY | 9.90 | 5 | 0.00 |
| KOREA, REPUBLIC OF | 8.67 | 23 | 0.00 |
| BELGIUM | 3.54 | 4 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 4.38 | 31 | 0.00 |
| DELHI AIR CARGO | 0.03 | 12 | 0.00 |
| HO CHI MINH CITY | 2.62 | 10 | 0.00 |
| EZEIZA | 52.38 | 9 | 0.00 |
| AEROPUERTO COM. A. MERINO B | 8.04 | 8 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| PFIZER LIMITED LIABILITY COMPANY | 3.54 | 532 |
| ASTRAZENECA SOCIEDAD ANONIMA | 9.88 | 879 |
| AMGEN BIOTECHNOLOGY OF ARGENTI | 46.64 | 24 |
| JOHNSON AND JOHNSON PRIVATE LIMITED | 4.33 | 3182 |
| SAVAL LABORATORIES SA | 3.49 | 479 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Infliximab—access key decision-makers and detailed reports to save time and succeed.
Infliximab Import Market
Explore Product Infliximab with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30021300 | INFLIXIMAB (QTY: 3 X 0.5 ML VALUE USD: 13.00/EACH) (FOC) |  |
|
KOREA, REPUBLIC OF | INDIA | 0.00006 |
| 30021300 | INFLIXIMAB (QTY: 2 X 1 ML, VALUE USD: 13.01/EACH) (FOC) | |
|
KOREA, REPUBLIC OF | INDIA | 0.00008 |
| 30021300 | INFLIXIMAB (QTY: 1 X 10 ML, VALUE USD: 13.05) (FOC) | |
|
KOREA, REPUBLIC OF | INDIA | 0.0004 |
| 30021500 | SIM0006 ANTI-HUMAN TNFA (INFLIXIMAB BIOSIMILAR) INVIVOSIMCLONE INFLIXIMAB, 1(FOR RUO | |
|
UNITED STATES | INDIA | 1 |
| 010290 | TEMP +3C AVSOLA 100 MG VIAL.1PK INFLIXIMAB LOADED ON 16 PALLETS SHIPPER QTY 320 | |
|
LA, LAO | USA | 320 |
| 070200 | TEMP +3C AVSOLA 100MG VIAL, 1 PK INFLIXIMAB LOADED ON 15 PALLETS SHIPPER QTY 300 | |
|
LA, LAO | USA | 300 |
| 070200 | TEMP +3C AVSOLA 100MG VIAL, 1 PK INFLIXIMAB LOADED ON 15 PALLETS SHIPPER QTY 300 | |
|
LA, LAO | USA | 300 |
| 854121 | TEMP +3C AVSOLA 100 MG VIAL,1 PK INFLIXIMAB LOADED ON 13 PALLETS SHIPPER QTY 260 | |
|
LA, LAO | USA | 260 |
| 853922 | TEMP +3C AVSOLA 100 MG VIAL.1PK INFLIXIMAB LOADED ON 15 PALLETS SHIPPER QTY 294 | |
|
LA, LAO | USA | 294 |
| 070200 | TEMP +3C AVSOLA 100MG VIAL, 1 PK INFLIXIMAB LOADED ON 15 PALLETS SHIPPER QTY 300 | |
|
LA, LAO | USA | 300 |
| 070200 | TEMP +3C AVSOLA 100MG VIAL, 1 PK INFLIXIMAB LOADED ON 15 PALLETS SHIPPER QTY 300 | |
|
LA, LAO | USA | 300 |
| 853922 | TEMP +3C AVSOLA 100 MG VIAL.1PK INFLIXIMAB LOADED ON 15 PALLETS SHIPPER QTY 294 | |
|
LA, LAO | USA | 294 |
| 010290 | TEMP +3C AVSOLA 100 MG VIAL.1PK INFLIXIMAB LOADED ON 16 PALLETS SHIPPER QTY 320 | |
|
LA, LAO | USA | 320 |
| 854121 | TEMP +3C AVSOLA 100 MG VIAL,1 PK INFLIXIMAB LOADED ON 13 PALLETS SHIPPER QTY 260 | |
|
LA, LAO | USA | 260 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Infliximab export markets
Discover Products Infliximab with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3002130000 | 54.99 | 192 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30021590300 | 5.78 | 9 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30021500 | 3.41 | 35 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30021300 | 1.42 | 4 | 0.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 30049099 | 0.26 | 34 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| KOREA, REPUBLIC OF | 29.04 | 103 | 0.00 |
| HUNGARY | 24.52 | 48 | 0.00 |
| PARAGUAY | 6.67 | 8 | 0.00 |
| HONG KONG | 3.17 | 6 | 0.00 |
| SOUTH AFRICA | 1.02 | 3 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| ISTANBUL AIRPORT CUSTOMS DIRECTORATE | 28.88 | 141 | 0.00 |
| BOMBAY AIR CARGO | 5.01 | 78 | 0.00 |
| MURATBEY CUSTOMS DIRECTORATE | 24.52 | 48 | 0.00 |
| EZEIZA | 5.78 | 9 | 0.00 |
| DELHI AIR CARGO | 0.11 | 4 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| PFIZER SOCIEDAD DE RESPONSABILIDAD LIMITADA | 5.78 | 66 |
| GENSENTA MEDICINE INDUSTRY AND TRADE ANONYMOUS COMPANY | 11.24 | 34 |
| LOGISTICS BUSINESS SERVICES SOCIEDAD DE RESPONSABILIDAD LIMITED | 1.30 | 146 |
| GENSENTA PHARMACEUTICAL INDUSTRY AND TRADE JOINT STOCK COMPANY | 42.60 | 444 |
| RELIANCE LIFE SCIENCES PRIVATE LIMITED | 4.72 | 607 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| HOPERAY INTERNATIONAL CO LIMITED | 3.17 | 7 |
| MINISTERE DE LA DEFENSE NATTONALE | 0.12 | 4 |
| CELLTRION INC | 53.83 | 409 |
| MEDPRO PHARMACEUTICA PTY LIMITED | 1.02 | 666 |
| MINISTERE DE LA DEFENSE NATIONALE | 0.31 | 10 |
Access the complete database of 29 buyers and 25 suppliers with a one-time subscription plan.
Infliximab Export Market
Analyze HSN Code Infliximab with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30021500 | [TAX INV.NO. THC000025; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION [REMICADE] | |
|
INDIA | CAYMAN ISLANDS | 3 |
| 30021500 | [TAX INV.NO. THC000012; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB INJECTION (REMICADE 100) | |
|
INDIA | CAYMAN ISLANDS | 5 |
| 30021210 | [TAX INV.NO. RBC003299; GSTIN. 27AASFR8882R1ZO] INFLIXIMAB INJETION (REMICADE 100MG) | |
|
INDIA | CAYMAN ISLANDS | 4 |
| 30021500 | [TAX INV.NO. THC000007; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 6 |
| 30021500 | [TAX INV.NO. THC000025; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION [REMICADE] | |
|
INDIA | CAYMAN ISLANDS | 3 |
| 30021210 | [TAX INV.NO. RBC003299; GSTIN. 27AASFR8882R1ZO] INFLIXIMAB INJETION (REMICADE 100MG) | |
|
INDIA | CAYMAN ISLANDS | 4 |
| 30021210 | [TAX INV.NO. RBC003299; GSTIN. 27AASFR8882R1ZO] INFLIXIMAB INJETION (REMICADE 100MG) | |
|
INDIA | CAYMAN ISLANDS | 2 |
| 30021210 | [TAX INV.NO. RBC003299; GSTIN. 27AASFR8882R1ZO] INFLIXIMAB INJETION (REMICADE 100MG) | |
|
INDIA | CAYMAN ISLANDS | 2 |
| 30021500 | [TAX INV.NO. THC000006; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 6 |
| 30021500 | [TAX INV.NO. THC000028; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 3 |
| 30021500 | [TAX INV.NO. THC000028; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 1 |
| 30021500 | [TAX INV.NO. THC000012; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB INJECTION (REMICADE 100) | |
|
INDIA | CAYMAN ISLANDS | 1 |
| 30021500 | [TAX INV.NO. THC000028; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 2 |
| 30021500 | [TAX INV.NO. THC000013; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB INJECTION (REMICADE 100) | |
|
INDIA | CAYMAN ISLANDS | 9 |
| 30021500 | [TAX INV.NO. THC000014; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB INJECTION (REMICADE 100) | |
|
INDIA | CAYMAN ISLANDS | 6 |
| 30021500 | [TAX INV.NO. THC000001; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 6 |
| 30021500 | [TAX INV.NO. THC000006; GSTIN. 27AANFT3310M1ZW] INFLIXIMAB 100MG INJECTION (REMICADE) | |
|
INDIA | CAYMAN ISLANDS | 6 |
| 30021210 | INFLIXIMAB INJECTION 100MG BRAND REMICADE 100 INJECTION | |
|
INDIA | KENYA | 10 |
| 30021210 | INFLIXIMAB INJECTION 100MG BRAND:REMICADE 100 INJECTION BATCH:NFM51011 MFG DT :JUN-23 EXP DT:MAY-26 | |
|
INDIA | KENYA | 20 |
| 30021210 | INFLIXIMAB INJECTION 100MG BRAND:REMICADE 100 INJECTION BATCH:NFM51011 MFG DT :JUN-23 EXP DT:MAY-26 | |
|
INDIA | KENYA | 20 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.